Caricamento...
Use of Cannabinoids as a Novel Therapeutic Modality Against Autoimmune Hepatitis
Autoimmune hepatitis is a severe immune mediated chronic liver disease with a prevalence range between 50 and 200 cases per million in Western Europe and North America and mortality rates of up to 80% in untreated patients. The induction of CB1 and CB2 cannabinoid receptors during liver injury and t...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2009
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4139007/ https://ncbi.nlm.nih.gov/pubmed/19647124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0083-6729(09)81019-4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|